Follow
Vincent Wai-Sun Wong
Title
Cited by
Cited by
Year
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
M Eslam, PN Newsome, SK Sarin, QM Anstee, G Targher, ...
Journal of hepatology 73 (1), 202-209, 2020
34692020
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
M Eslam, AJ Sanyal, J George, A Sanyal, B Neuschwander-Tetri, ...
Gastroenterology 158 (7), 1999-2014. e1, 2020
28032020
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, ...
Hepatology 78 (6), 1966-1986, 2023
21032023
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta‐analysis
PS Dulai, S Singh, J Patel, M Soni, LJ Prokop, Z Younossi, G Sebastiani, ...
Hepatology 65 (5), 1557-1565, 2017
17972017
Non-alcoholic fatty liver disease
EE Powell, VWS Wong, M Rinella
The Lancet 397 (10290), 2212-2224, 2021
17712021
Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Z Younossi, F Tacke, M Arrese, B Chander Sharma, I Mostafa, ...
Hepatology 69 (6), 2672-2682, 2019
17502019
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ...
The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018
15902018
Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease
VWS Wong, J Vergniol, GLH Wong, J Foucher, HLY Chan, B Le Bail, ...
Hepatology 51 (2), 454-462, 2010
15322010
New trends on obesity and NAFLD in Asia
JG Fan, SU Kim, VWS Wong
Journal of hepatology 67 (4), 862-873, 2017
10882017
Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer
J Yu, Q Feng, SH Wong, D Zhang, Q yi Liang, Y Qin, L Tang, H Zhao, ...
Gut 66 (1), 70-78, 2017
10272017
Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis
T Karlas, D Petroff, M Sasso, JG Fan, YQ Mi, V de Lédinghen, M Kumar, ...
Journal of hepatology 66 (5), 1022-1030, 2017
10192017
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis
J Li, B Zou, YH Yeo, Y Feng, X Xie, DH Lee, H Fujii, Y Wu, LY Kam, F Ji, ...
The lancet Gastroenterology & hepatology 4 (5), 389-398, 2019
9292019
Nonalcoholic fatty liver disease
EM Brunt, VWS Wong, V Nobili, CP Day, S Sookoian, JJ Maher, ...
Nature reviews Disease primers 1 (1), 1-22, 2015
8712015
Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years
VWS Wong, GLH Wong, PCL Choi, AWH Chan, MKP Li, HY Chan, ...
Gut 59 (7), 969-974, 2010
8202010
Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis
RS Taylor, RJ Taylor, S Bayliss, H Hagström, P Nasr, JM Schattenberg, ...
Gastroenterology 158 (6), 1611-1625. e12, 2020
8172020
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
P Jiang, CWM Chan, KCA Chan, SH Cheng, J Wong, VWS Wong, ...
Proceedings of the National Academy of Sciences 112 (11), E1317-E1325, 2015
7312015
Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients
N Lee, KCA Chan, DS Hui, EKO Ng, A Wu, RWK Chiu, VWS Wong, ...
Journal of clinical virology 31 (4), 304-309, 2004
7302004
A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
SL Friedman, V Ratziu, SA Harrison, MF Abdelmalek, GP Aithal, ...
Hepatology 67 (5), 1754-1767, 2018
7242018
Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates
Z Younossi, M Stepanova, JP Ong, IM Jacobson, E Bugianesi, A Duseja, ...
Clinical gastroenterology and hepatology 17 (4), 748-755. e3, 2019
7142019
Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study
E Vilar-Gomez, L Calzadilla-Bertot, VWS Wong, M Castellanos, ...
Gastroenterology 155 (2), 443-457. e17, 2018
7102018
The system can't perform the operation now. Try again later.
Articles 1–20